[Cardiac troponin].
Alma M A Mingels1, Ton P M Gorgels, Marja P van Dieijen-Visser
1Afd. Klinische chemie, Maastricht Universitair Medisch Centrum, Maastricht, the Netherlands. alma.mingels@mumc.nl
Nederlands Tijdschrift Voor Geneeskunde
|October 19, 2012
Summary
High-sensitivity troponin assays enable earlier acute myocardial infarction diagnosis. A typical rise or fall in troponin levels is crucial for confirming acute myocardial infarction diagnosis.
Area of Science:
- Cardiology
- Biomarkers
- Diagnostic Medicine
Background:
- Cardiac troponins (cTnT, cTnI) are gold standard biomarkers for acute coronary syndrome diagnosis.
- New high-sensitivity troponin assays offer improved diagnostic capabilities.
- Establishing new diagnostic cut-off concentrations is essential.
Observation:
- Two male patients presented with acute chest pain but lacked ST-segment elevation on EKG.
- Case 1 demonstrated early acute myocardial infarction diagnosis using high-sensitivity troponin assays.
- Case 2 highlighted the necessity of observing troponin concentration trends (rise/fall) for diagnosis.
Findings:
- High-sensitivity troponin assays significantly enhance the early detection of acute myocardial infarction.
- The diagnostic accuracy relies on understanding assay sensitivity, specificity, and reference values.
- A typical dynamic change in troponin levels is critical for confirming myocardial infarction.
Implications:
- These assays facilitate earlier and more accurate diagnosis of acute myocardial infarction.
- Clinical interpretation requires careful consideration of assay performance characteristics and patient context.
- Further research into reference change values will refine diagnostic protocols for myocardial infarction.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:28Imaging Studies for Cardiovascular System V: CT
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...